Genentech Dumps Another $650M in New Haven Biotech Arvinas Post author:Sam Post published:November 14, 2017 Post category:BioPharma Arvinas expanded an ongoing licensing deal with Genentech. Source: BioSpace You Might Also Like Oramed Appoints As Chief Strategy Officer March 20, 2017 Astrazeneca Gets Another Boost With FDA Approval of Severe Asthma Drug November 14, 2017 INC Research Schedules Fourth Quarter And Year End 2016 Earnings Call For Tuesday, February 28, 2017 February 6, 2017
INC Research Schedules Fourth Quarter And Year End 2016 Earnings Call For Tuesday, February 28, 2017 February 6, 2017
